CLB Core Laboratories Inc. /DE/
CLB financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
▼ Key Metrics (TTM)
As of Jun 30, 2026Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $526.52M | $523.85M | $509.79M |
| Cost of Revenue | $417.59M | $420.52M | $399.96M |
| Gross Profit | $108.93M | $103.33M | $109.83M |
| OPERATING EXPENSES | |||
| SG&A Expense | $45.43M | $39.77M | $40.26M |
| Operating Income | $56.47M | $58.56M | $54.64M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Expense | $10.57M | $12.37M | $13.43M |
| Other Income/Expense | $7.61M | $9.95M | $850.00K |
| Pretax Income | $45.90M | $46.19M | $41.21M |
| Income Tax | $15.51M | $14.03M | $4.19M |
| Net Income | $29.67M | $31.40M | $36.68M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $0.63 | $0.66 | $0.77 |
| Diluted Shares | 47.03M | 47.69M | 47.52M |
| EBITDA | $71.12M | $73.51M | $70.42M |
| Depreciation & Amortization | $14.65M | $14.95M | $15.78M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $22.70M | $19.16M | $15.12M |
| Accounts Receivable | $113.53M | $111.76M | $109.35M |
| Inventory | $54.50M | $59.40M | $71.70M |
| Other Current Assets | $6.94M | $10.52M | $5.09M |
| Current Assets | $214.67M | $226.61M | $223.14M |
| PP&E (Net) | $99.45M | $97.06M | $99.63M |
| Goodwill | $105.79M | $99.45M | $99.45M |
| Intangible Assets | $7.12M | $6.40M | $6.93M |
| Other Noncurrent Assets | $35.26M | $34.79M | $34.22M |
| Noncurrent Assets | $369.35M | $363.80M | $363.26M |
| Total Assets | $584.01M | $590.41M | $586.40M |
| LIABILITIES | |||
| Accounts Payable | $37.28M | $34.55M | $33.51M |
| Other Current Liabilities | $16.68M | $8.16M | $7.65M |
| Current Liabilities | $106.02M | $97.59M | $88.10M |
| Long-term Debt | $110.26M | $126.11M | $163.13M |
| Other Noncurrent Liabilities | $15.85M | $20.73M | $20.04M |
| Noncurrent Liabilities | $205.79M | $235.08M | $268.49M |
| Total Liabilities | $311.80M | $332.67M | $356.59M |
| EQUITY | |||
| Common Stock | $470.00K | $470.00K | $469.00K |
| Additional Paid-in Capital | $110.25M | $109.55M | $110.01M |
| Retained Earnings | $172.66M | $150.28M | $120.76M |
| Accumulated OCI | $-5.81M | $-5.77M | $-4.97M |
| Total Equity | $272.21M | $257.74M | $229.81M |
| Total Liabilities & Equity | $584.01M | $590.41M | $586.40M |
| SUPPLEMENTAL | |||
| Shares Outstanding | 46.10M | 46.83M | 46.86M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $37.03M | $56.39M | $24.79M |
| Capital Expenditures | $11.21M | $11.89M | $10.58M |
| Cash from Investing | $-2.23M | $-6.39M | $-6.65M |
| Cash from Financing | $-31.26M | $-45.96M | $-18.45M |
| Free Cash Flow | $25.82M | $44.50M | $14.21M |
| Beginning Cash (CFS) | $19.16M | $15.12M | $15.43M |
| Net Change in Cash | $3.55M | $4.04M | $-308.00K |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $22.70M | $19.16M | $15.12M |
| Cash per BS | $22.70M | $19.16M | $15.12M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $22.70M | $19.16M | $15.12M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log InQuarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is Core Laboratories Inc. /DE/'s annual revenue?
Core Laboratories Inc. /DE/ reported $519.18M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is Core Laboratories Inc. /DE/ profitable?
Yes. Core Laboratories Inc. /DE/ reported $24.35M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Does Core Laboratories Inc. /DE/ generate free cash flow?
Yes. Free cash flow was $15.14M for trailing twelve months. Operating cash flow was $28.22M.
Fundamentals Hub